The plaintiffs in a quartet of lawsuits filed against Intuitive Surgical (NSDQ:ISRG) want the cases consolidated under a single judge in either Louisiana or California, according to court documents.
Intuitive Surgical
Occlutech claims win in Dutch legal war with St. Jude Medical | Legal News
Occlutech GmbH is claiming victory in a legal battle with St. Jude Medical (NYSE:STJ) over structural heart implants, saying Holland’s Supreme Court upheld an earlier ruling in Occlutech’s favor.
MassDevice.com +7 | The top 7 med-tech stories for the week of May 21, 2012.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
Does a robot-assisted prostatectomy cost more?
Robot-assisted prostate surgery may be a profit-sink for hospitals, according to a new study set to be published in the July issue of the journal Urology.
Boston Scientific’s CEO defends the troubled Guidant buyout | Wall Street Beat
Boston Scientific’s (NYSE:BSX) interim CEO Hank Kucheman still believes in the company’s ill-fated acquisition of Guidant Corp., a deal worth $26 billion that was followed by recalls, lawsuits and criminal charges.
Botched hysterectomy lawsuit claims Intuitive Surgical markets through “intimidation”
Another patient lawsuit joined the bandwagon this week in claiming Intuitive Surgical’s (NSDQ:ISRG) da Vinci robot-assisted surgery system was to blame in a botched hysterectomy, this one claiming that the device’s proliferation is owed in part to overly aggressive marketing practices.
MassDevice.com +3 | The top 3 med-tech stories for May 7, 2012.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Accuray CEO Euan Thomson: CyberKnife is the “true robotic system”
Prostate cancer: To cut or not to cut?
Early results from a long-term study of prostate cancer patients concluded that removal of the gland barely increased the likelihood for survival in patients with low-risk tumors, concluding that the surgical approach "may be neither necessary nor effective."
MassDevice.com +7 | The top 7 med-tech stories for the week of April 23, 2012.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
MassDevice.com +3 | The top 3 med-tech stories for April 26, 2012.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.